|
Aside from US based clients, Bioprocess
Pty Ltd is a direct supplier and
licensor to partners overseas,
primarily, but not exclusively, to
European corporations. Very limited
attention has been paid towards the
rapidly growing markets developing in
South East Asia. Bioprocess Pty Ltd
seeks to identify an Australian
biomedical partner company with
established business links and interests
in this region with a view to creating a
joint effort. Such an effort should
constitute an opportunity to explore, in
a coherent manner, this important
market.
Exploitation of gene-technology based
recombinant source ingredients already
available is only one aspect of a
contemplated joint venture, however.
With the rapid essentially automated
accumulation of new sequence
data,
it is becoming clear that the bottleneck
has already moved away from the
acquisition of
raw
sequence information to all aspects of
proteomics, including the need to
develop suitable expression formats for
an overabundance of new polypeptides
inferred from the on-going efforts in
genomics. No single company is able to
exploit but a fraction of the
opportunities emerging. However,
Bioprocess Pty Ltd is well positioned to
expand current
activities to encompass some of these
opportunities. The rapid success of such
a broadened task would obviously benefit
from the synergy implicit in a
partnership where complementary
strengths of the participants are
brought to bear. Ideally, therefore,
Bioprocess is interested in contacts
with firms having a similar outlook and
contemplating the pursuit of strategies
which harmonize with those of
Bioprocess.
Optimally, a partner company might have
either:
-
Business activities/contacts
both in Australia and South East
Asia (Possibly including China,
India, Japan).
-
Research Activity (possibly
outsourced but preferably
in-house) in some aspects of
proteomics or genomics.
-
A
need to access proprietary
expression technology/protein
biochemistry.
-
An
interest in forming a JV in
Australia with Bioprocess Pty
Ltd to pursue the goals
delineated above, and targeting
early cash-flow and revenues.
If you are
interested in exploring Joint Venture
opportunities, then please
contact us. |